Search

Abul Tarafder (University of Oxford) and colleagues published a paper in PNAS showing how the phage Pf4 forms a sheath made of liquid crystalline droplets around its host, Pseudomonas aeruginosa, which protects it from antibiotics and more.

A new monthly podcast called Superbugs Unplugged covers antimicrobial resistance news (and even covers phages, in episode two!).

A new monthly podcast called Superbugs Unplugged covers antimicrobial resistance news (and even covers phages, in episode two!).

If you can get to Hamilton, Ontario Nov 14-15, check out the 2019 Gairdner Symposium: Fuelling the Fight Against Antimicrobial Resistance. Speakers include Dame Sally Davies (UK special envoy on AMR), Kevin Outterson (Director of CarbX), au

If you can get to Hamilton, Ontario Nov 14-15, check out the 2019 Gairdner Symposium: Fuelling the Fight Against Antimicrobial Resistance. Speakers include Dame Sally Davies (UK special envoy on AMR), Kevin Outterson (Director of CarbX), au

Antimicrobial Resistance (AMR) Interdisciplinary Research Group of Singapore-MIT Alliance for Research and Technology is seeking a full-time Laboratory Assistant or Laboratory Technologist to join a dynamic team working on antibacterial dru

Antimicrobial Resistance (AMR) Interdisciplinary Research Group of Singapore-MIT Alliance for Research and Technology is seeking a full-time Laboratory Assistant or Laboratory Technologist to join a dynamic team working on antibacterial dru

Boston, MA CARB-X, a Boston University Global Partnership, has an exciting opportunity for a talented individual to join our core team at Boston University in the role of Director of Research & Development. CARB-X is a new organization loca

Boston, MA CARB-X, a Boston University Global Partnership, has an exciting opportunity for a talented individual to join our core team at Boston University in the role of Director of Research & Development. CARB-X is a new organization loca

We are looking for a highly motivated and dynamic researcher for a 2 year position, to commence August 1, 2019. The position is related to role of bacteriophages in the transfer of antibiotic resistance genes in Staphylococcus and the exten

We are looking for a highly motivated and dynamic researcher for a 2 year position, to commence August 1, 2019. The position is related to role of bacteriophages in the transfer of antibiotic resistance genes in Staphylococcus and the exten

CARB-X, a Boston University Global Partnership, has an exciting opportunity for a talented individual to join our core team at Boston University in the role of Director of Research & Development. CARB-X is a new organization located at the

CARB-X, a Boston University Global Partnership, has an exciting opportunity for a talented individual to join our core team at Boston University in the role of Director of Research & Development. CARB-X is a new organization located at the

The study characterizes P9ly, a lytic enzyme from bacteriophage PSD9. In laboratory experiments, it showed bacteriolytic and bactericidal activity against multidrug-resistant Shigella dysenteriae and Staphylococcus aureus strains; combining

Terminated. Checked 2026-10-03. This is a phase I/II trial designed to evaluate bacteriophage therapy in patients with urinary tract infections. A Phase I/II Study of Bacteriophage Therapy to Evaluate Safety, Tolerability, and Efficacy of T

Recruiting. Checked 2026-10-03. EPHICACI is a multicenter, prospective study that continues and expands the monocentric PHAGEFORCE registry initiated at UZ Leuven. In Belgium, phage therapy can be applied as standard-of-care only in patient